Inhibition of the P2X7 receptor prevents atrial proarrhythmic remodeling in experimental post-operative atrial fibrillation

Int Immunopharmacol. 2024 Mar 10:129:111536. doi: 10.1016/j.intimp.2024.111536. Epub 2024 Feb 5.

Abstract

Background: Post-operative atrial fibrillation (POAF) is a common complication in patients undergoing cardiac surgery. The purinergic receptor P2X7 (P2X7R) is involved in some cardiovascular diseases, whereas its effects on atrial fibrillation (AF) are unclear.

Objective: This study was to assess the effect of P2X7R on atrial arrhythmogenic remodeling in the rat model of sterile pericarditis (SP).

Methods: Male Sprague-Dawley (SD) rats were used to induce the SP model. Electrocardiogram, atrial electrophysiological protocol, histology, mRNA sequencing, real-time quantitative PCR, western blot, and Elisa assay were performed.

Results: SP significantly up-regulated P2X7R expression; increased AF susceptibility; reduced the protein expression of ion channels including Nav1.5, Cav1.2, Kv4.2, Kv4.3, and Kv1.5; caused atrial fibrosis; increased norepinephrine (NE) level in plasma; promoted the production of inflammatory cytokines such as TNF-α, IL-1β, and IL-6; increased the accumulation of immune cells (CD68- and MPO- positive cells); and activated NLRP3 inflammasome signaling pathway. P2X7R antagonist Brilliant Blue G (BBG) mitigated SP-induced alterations. The mRNA sequencing demonstrated that BBG prevented POAF mainly by regulating the immune system. In addition, another selective P2X7R antagonist A740003, and IL-1R antagonist anakinra also reduced AF inducibility in the SP model.

Conclusions: P2X7R inhibition prevents SP-induced atrial proarrhythmic remodeling, which is closely associated with the improvement of inflammatory changes, ion channel expression, atrial fibrosis, and sympathetic activation. The findings point to P2X7R inhibition as a promising target for AF (particularly POAF) and perhaps other conditions.

Keywords: Inflammation; NLRP3 inflammasome; P2X7 receptor; Post-operative atrial fibrillation.

MeSH terms

  • Animals
  • Atrial Fibrillation* / drug therapy
  • Atrial Fibrillation* / etiology
  • Atrial Fibrillation* / prevention & control
  • Fibrosis
  • Humans
  • Male
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Pericarditis*
  • RNA, Messenger
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2X7 / genetics

Substances

  • Receptors, Purinergic P2X7
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • RNA, Messenger